Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Replimune Group Inc (REPL)

Replimune Group Inc (REPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 395,953
  • Shares Outstanding, K 61,388
  • Annual Sales, $ 0 K
  • Annual Income, $ -174,280 K
  • 60-Month Beta 1.21
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.98
Trade REPL with:

Options Overview Details

View History
  • Implied Volatility 143.02% ( +9.78%)
  • Historical Volatility 51.11%
  • IV Percentile 74%
  • IV Rank 34.75%
  • IV High 342.19% on 10/20/23
  • IV Low 36.97% on 05/17/23
  • Put/Call Vol Ratio 0.18
  • Today's Volume 39
  • Volume Avg (30-Day) 47
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 2,799
  • Open Int (30-Day) 3,420

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.86
  • Number of Estimates 5
  • High Estimate -0.74
  • Low Estimate -1.05
  • Prior Year -0.74
  • Growth Rate Est. (year over year) -16.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.22 +3.22%
on 04/22/24
8.46 -24.11%
on 03/28/24
-1.78 (-21.71%)
since 03/22/24
3-Month
6.22 +3.22%
on 04/22/24
9.20 -30.22%
on 03/11/24
-1.43 (-18.22%)
since 01/22/24
52-Week
5.89 +9.00%
on 12/05/23
24.81 -74.12%
on 06/15/23
-10.83 (-62.78%)
since 04/21/23

Most Recent Stories

More News
Down -22% in 4 Weeks, Here's Why Replimune Group, Inc. (REPL) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Replimune Group, Inc. (REPL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street...

REPL : 6.42 (-0.47%)
Replimune Group, Inc. (REPL) Loses -14.58% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Replimune Group, Inc. (REPL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings...

REPL : 6.42 (-0.47%)
Replimune Group, Inc. (REPL) is on the Move, Here's Why the Trend Could be Sustainable

Replimune Group, Inc. (REPL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through...

REPL : 6.42 (-0.47%)
Wall Street Analysts Think Replimune Group, Inc. (REPL) Could Surge 87.88%: Read This Before Placing a Bet

The consensus price target hints at an 87.9% upside potential for Replimune Group, Inc. (REPL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

REPL : 6.42 (-0.47%)
Recent Price Trend in Replimune Group, Inc. (REPL) is Your Friend, Here's Why

Replimune Group, Inc. (REPL) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

REPL : 6.42 (-0.47%)
Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks

This billionaire-guided hedge fund went bargain-shopping in the second quarter.

AFMD : 5.00 (-2.91%)
CERS : 1.6900 (+0.60%)
REPL : 6.42 (-0.47%)
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update

Target enrollment of 180 patients reached in the CERPASS randomized controlled registration-directed clinical trial evaluating RP1 in cutaneous squamous...

REPL : 6.42 (-0.47%)
Replimune to Present at Two Upcoming Investor Conferences

WOBURN, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development...

REPL : 6.42 (-0.47%)
Replimune Announces the Departure of Jason Rhodes from its Board of Directors

WOBURN, Mass., June 03, 2022 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development...

REPL : 6.42 (-0.47%)
Replimune To Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Presentations include recently updated results from the skin cancer cohort of IGNYTE, an ongoing Phase 1/2 study of RP1 combined with Opdivo® (nivolumab),...

REPL : 6.42 (-0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Replimune Group, Inc. is a clinical-stage biotechnology company. It discovers, develops and commercializes oncolytic immunotherapy for the treatment of cancer diseases. The company's product pipeline consists of RP1, RP2 & RP3 which are in clinical stage. Replimune Group, Inc. is based in MA, United...

See More

Key Turning Points

3rd Resistance Point 7.10
2nd Resistance Point 6.89
1st Resistance Point 6.65
Last Price 6.42
1st Support Level 6.20
2nd Support Level 5.99
3rd Support Level 5.75

See More

52-Week High 24.81
Fibonacci 61.8% 17.58
Fibonacci 50% 15.35
Fibonacci 38.2% 13.12
Last Price 6.42
52-Week Low 5.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar